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 Abstract
ABC multidrug transporters are key players in cancer multidrug resistance and in
determining the ADME-Tox properties of drugs and xenobiotics. The most sensitive
and specific detection of these transporters is based on functional assays. Assessment of
the transporter-dependent reduction of cellular uptake of the fluorescent dyes, such as
Hoechst 33342 (Ho) and more recently DyeCycle Violet (DCV), have been widely
advocated for the characterization of both ABCB1 and ABCG2 multidrug transporters.
Detailed comparison of these supravital DNA-binding dyes revealed that DCV is less
toxic to ABCG2- and ABCB1-expressing cells than Ho. ATPase measurements imply
that DCV and Ho are similarly handled by ABCB1, whereas ABCG2 seems to transport
DVC more effectively. In addition, we have developed an image-based high content
microscopy screening method for simultaneous in situ measurement of the cellular
activity and expression of the ABCG2 multidrug transporter. We demonstrated the
applicability of this method for identifying ABCG2-positive cells in heterogeneous cell
population by a single dye uptake measurement. These results may promote multidrug
transporter studies at a single cell level and allow the quantitative detection of clinically
important drug-resistant sub-populations. VC 2016 International Society for Advancement of
Cytometry
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MULTIDRUG resistance is a major problem in chemotherapy of cancer or in pro-
longed viral infections. An important cause of the emergence of cellular multidrug
resistance is the increased expression of ABC multidrug transporters (1,2). Three
human ABC proteins, ABCB1, ABCG2, and ABCC1 are the key membrane proteins
responsible for an increased outward drug transport in most multidrug-resistant
cells. These transporters are members of the ancient ABC transporter protein family,
performing primary, ATP-dependent active transport processes. The human multi-
drug transporters consist of conserved cytoplasmic ABC domains, responsible for
the ATP binding and hydrolysis, and multipass membrane region(s) involved in drug
substrate binding and outward drug transport (3,4). The above mentioned three
human multidrug transporters show promiscuous drug binding characteristics and
have partially overlapping substrate specificities. Prediction of interactions between
ABC multidrug transporters and drugs is a challenging task, because the structure of
these proteins is not known at an atomic level, and the drug-protein interaction site
is probably a large and versatile interface (5).
Both in vitro and in vivo studies clearly indicate that in multidrug-resistant cells
the therapeutically effective drug concentrations strongly depend on the actual, func-
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tional expression levels of the ABC multidrug transporters. In
humans, ABC multidrug transporters are expressed in all
major tissue barriers; and ABCG2 is specifically expressed in
various stem cells. Moreover, in normal or cancer cell popula-
tions the expression levels of drug transporters highly vary
from cell to cell. An important example for this variability is
the suggested presence of cancer stem cells in malignant
tumors (1,6–8). It has been widely documented that cancer
stem cells express relatively high, protective levels of multi-
drug transporters, especially the ABCG2 and/or the ABCB1
proteins, providing the so-called side-population (SP) pheno-
type (2). Thus, a single cell functional detection of the ABC
multidrug transporter proteins, preferably in live and surviv-
ing cells, has a major importance.
In the present report we provide a detailed comparison
of the cellular interactions of two fluorescent supravital dyes,
transported substrates of both ABCB1 and ABCG2. The
Hoechst 33342 (Ho) dye has already been widely applied in
cellular studies, while the recently developed DyeCycle Violet
(DCV) has been less characterized in this respect (9–13). Both
DCV and Ho are DNA binding dyes, and become fluorescent
only in a DNA-bound form. This property promotes the use
of these dyes in continuous dye uptake measurements, or even
in in situ microscopy settings, without washing of the cells.
DCV was originally developed as a cell cycle marker by Molec-
ular ProbesTM, and the fluorescence properties render it more
applicable than Ho for measurements by using violet (exc.
405 nm) lasers, available in most cell biology instruments.
Although DCV has already been used to identify and sort
drug-resistant side population cells based on a transporter
related reduction of DCV uptake (9,10,13), a detailed analysis
of DCV-transporter interactions has not been provided.
In the present study, we performed detailed direct ABC
transporter interaction assays by using both dyes, examined
their cellular toxicity in parental and drug-resistant cell popu-
lations, and followed the modulation of DCV and Ho accu-
mulation by specific transporter inhibitors. Moreover, we
have performed high content screening assays to reveal the in
situ kinetics of the modulation of dye uptake by ABCG2, par-
allel with a specific antibody staining of the transporter. These
approaches allow the identification of various functional
ABCG2 expression levels in a mixed, live cell population.
MATERIALS AND METHODS
Materials
Unless otherwise stated, all reagents were obtained from
Sigma–Aldrich. DyeCycle Violet, FIX & PERM
VR
Cell Fixation
& Cell Permeabilization Kit and Hoechst 33342 were obtained
from Thermo Fisher Scientific. The 5D3 antibody was purified
from 5D3 hybridoma cell line (a kind gift of Dr. Brian Sorren-
tino) and labeled with AlexaFluor647 as described previously
(14). The MRK-16 antibody was obtained from Kamiya Bio-
medical Company. Ko143 was obtained from Tocris
Bioscience.
Cell Lines
Previously we have generated ABCB1- and ABCG2-
overexpressing K562, and ABCB1-, ABCC1-, and ABCG2-
overexpressing A431 cell lines by retroviral transduction
(15,16). The expression and function of ABC transporters in
these cell lines were examined by antibody staining and dye
extrusion assays, respectively, as detailed below. Parental,
ABCB1- and ABCG2-expressing A431 cells were also modified
to express cytosolic mOrange fluorescent protein (ex: 548, em:
562) by lentiviral transduction. Generation of cell lines was
performed with the support of Creative Cell (Budapest, Hun-
gary). Sf9 insect cells used for ATPase assays were infected
with recombinant baculoviruses harboring ABCB1 and
ABCG2 as described previously (17).
Membrane ATPase Measurements
ATPase activity of ABC transporters was measured in
membrane vesicles prepared from insect (Sf9) cells expressing
human wild type ABCB1 or ABCG2 (17). In order to ensure
maximal ABCG2 activity, Sf9 membranes were loaded with
cholesterol to the level of the mammalian type membranes, as
described previously (18). Vanadate-sensitive ATPase activity
of ABCB1 and ABCG2 was measured by a colorimetric reac-
tion (19).
Cytotoxicity Assay
DCV and Ho cytotoxicity was measured in viability
assays by using K562 and A431 cells expressing the ABCB1 or
ABCG2 proteins. Viability assays were carried out in 96-well
plates. 1 3 104 K562 cells/well were seeded in RPMI media,
the DCV or the Ho dye was added in increasing concentra-
tions, and the plates were incubated for 72 h at 378C. For mea-
suring cell viability, the PrestoBlue reagent (Life Technologies)
was used as described earlier (20). In the case of A431 cells, 4
3 103 cells were seeded onto 96-well plates 24 h prior to the
addition of the examined dyes. Following a 72 h incubation
period, the viability was determined by the mOrange fluores-
cence of the cells. Preliminary experiments demonstrated close
correlation between the amount of cells and the measured
mOrange fluorescence (data not shown). Fluorescence (579/
25 nm) was detected by a Perkin Elmer Victor X3 2030 Multi-
label Plate Reader at 535/25 nm excitation, both for Pres-
toBlue and mOrange. Fluorescence of the untreated samples
considered as 100%. Cytotoxicity was determined by the IC50
values, calculated by Origin software (OriginLab) from the
viability curves.
Flow Cytometry for Fluorescent Dye Uptake
Measurements and for Immunostaining
Cell surface expression of the ABC transporters was fol-
lowed by labeling the cells with monoclonal antibodies that
recognize an external epitope of the given transporter. Anti-
ABCB1 MRK-16 and anti-ABCG2 5D3 primary antibodies
were used for this detection. 5 3 105 K562 or A431 cells were
incubated with the primary antibody (1 lg/ml) for 30 min at
378C. Labeling ABCG2 was performed in the presence of 5
lM Ko143 inhibitor to obtain maximal signal with the 5D3
conformation-sensitive antibody. After washing, the cells were
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2 ABCMultidrug Transporter Assay
further incubated with a secondary, Brilliant Violet 421 conju-
gated anti-mouse IgG antibody (BioLegend, 2 lg/ml). Fluo-
rescence was detected by an Attune Acoustic Focusing
Cytometer (B/V, Applied Biosystems). Functional activity of
the multidrug transporter proteins was measured by dye
uptake assays in flow cytometry. 5 3 105 cells were pre-
incubated in the absence or presence of the specific inhibitor
of the transporter protein in HPMI medium (120 mM NaCl,
5 mM KCl, 400 lM MgCl2, 40 lM CaCl2, 10 mM Hepes,
10 mM NaHCO3, 10 mM glucose, and 5 mM Na2HPO4) for
10 min at 378C. After preincubation, the cells were subjected
to DCV (1 lM) or Ho (1 lM) for 20 min at 378C. The uptake
was terminated by the addition of ice-cold PBS. After centrifu-
gation the cells were resuspended in PBS and fluorescence of
the samples was measured at 450/40 nm in an Attune flow
cytometer using 405 nm laser for excitation. The transport
activity of ABC transporters was characterized by the
“transport activity factor” calculated as follows: (F1002 F0)/
F100 3 100, where F0 is the fluorescence (median values) of
DCV/Ho-treated cells in the absence of an inhibitor; F100 is
the fluorescence (median values) in the presence of the inhibi-
tor (21). As transporter inhibitors, elacridar (5 lM), Ko143 (5
lM), and MK-571 (100 lM) were used for ABCB1, ABCG2,
and ABCC1, respectively.
High Content Screening Measurement of DyeCycle
Violet Uptake
A431 and A431/ABCG2 cells were used for High Content
Screening (HCS) measurements. To generate mixed popula-
tions, parental and ABCG2-expressing A431 cells were mixed
in a ratio of 98:2. The cells were seeded into a 96-well plate
(Cellstar, Greiner) at 4 3 103 cells/well density in 100 ml a-
MEM cell culture medium 16 h prior to the experiment. Dye
uptake measurement was carried out in an ImageXpress
Micro XLS High Content System (Molecular Devices, Sunny-
vale, CA, USA) with a Nikon CFI Super Plan Fluor ELWD
ADM 203 objective. The cells were incubated with 1 mM
DCV for 90 min at 378C, and then subjected to 5 mM Ko143
for an additional 60 min. The fluorescence of DCV (447/
60 nm) were acquired every 5 min at 377/50 nm excitation.
Immunodetection of ABCG2 by High Content
Screening
Following the DCV uptake measurement, the cells were
immunolabeled for ABCG2 as follows. Cells were washed
three times with Dulbecco’s modified phosphate-buffered
saline (DPBS) and fixed for 15 min at room temperature with
Fix&Perm A solution (Thermo F.S.). After four washes with
DPBS, non-specific antibody binding was blocked by
Fix&Perm B solution for 1 h, and the samples were stained by
AlexaFluor647-conjugated 5D3 anti-ABCG2 antibody (2 mg/
ml final concentration) for 1 h. After repeated washes with
DPBS, the plate was imaged by the High Content Screening
System. The fluorescence signals for DCV (447/60 nm) and
AlexaFluor647-labelled antibody staining (692/40 nm) were
acquired at 377/50 and 628/40 nm excitations, respectively.
High Content Data Analysis
To identify even a very small fraction of ABCG2-
expressing cells in a heterogeneous cell population, the
ImageXpress Micro XLS Widefield High Content Analysis
System and the MetaXpress High-Content Image Acquisition
and Analysis Software were used. Each well, containing a few
hundreds of cells, was imaged every 5 min throughout the
experiment as described above. During the analysis, an identi-
fication number (Object ID) was assigned to each cell. The
cells were tracked with Multi Dimensional Motion Analysis
(MDMA) application, which can follow the movement of the
cells in time and provide the average fluorescence intensity of
each nucleus at every time point using a series of mask images.
To generate a measure of DCV uptake for each cell, the fluo-
rescence intensities of the nuclei (F1 and F2) were determined
at two selected time points, 15 and 60 min, respectively, after
the addition of Ko143 (carried out after a 90 min incubation
with DCV). The “DCV transport ratio” for each cell with the
given Object ID was calculated as F2/F1. Using the last mask
image created by the MDMA application on the basis of the
blue fluorescence, the cells positive for 5D3 antibody staining
was identified by the Multi Wavelength Cell Scoring (MWCS)
application. MDMA data for DCV uptake and MWCS data
for immunostaining were compared to investigate the correla-
tion of these independent detections.
Statistical significance was performed using paired Stu-
dent’s t-test. P< 0.01 was considered as significant difference.
RESULTS
DCV and Ho Directly Interact With Both ABCB1 and
ABCG2 According to the ATPase Activity Assay
ABC multidrug transporters use the energy of ATP bind-
ing and hydrolysis for drug extrusion; ATPase activity and
drug transport are coupled processes. Therefore, drug sub-
strates and inhibitors significantly modify the ATPase activity
of the transporters in a concentration-dependent manner,
allowing an estimation of direct interactions with drugs (19).
In isolated membrane preparations containing the transporter
proteins, both ABCB1 and ABCG2 have a basal ATPase activi-
ty (without added substrate drug), which can be either stimu-
lated or inhibited by the interacting drugs. Rapidly
transported substrates usually activate ABC-ATPase, while
inhibitors or slowly transported compounds reduce the basal
and/or the drug-stimulated ATPase activity (17–19).
In this study the ATPase activity was measured in human
ABCG2- or ABCB1-containing cell membrane vesicles, pre-
pared from transporter-overexpressing Sf9 insect cells. The
relatively low basal ATPase activity of ABCB1 was not signifi-
cantly influenced by either DCV or Ho (Fig. F11A). In contrast,
drug-stimulated ABCB1-ATPase activity in the presence of
well-known substrates, including reversin 121 (or verapamil,
data not shown) was inhibited by both dyes in a
concentration-dependent manner (Fig. 1A). We found no sig-
nificant differences between DCV and Ho in terms of their
concentration-dependent reduction of this ATPase activity,
with approximate IC50 values of 3–5 lM (Fig. 1A).
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In the case of the ABCG2 protein, having a higher basal
ATPase activity, both the basal activity and the drug-
stimulated ATPase (induced by quercetin) were inhibited by
both DCV and Ho (Fig. 1B). The approximate IC50 value for
DCV (5 lM) was higher than that for Ho (about 1.5 lM),
suggesting a stronger interaction, which predicts slower trans-
port of Ho by ABCG2. These results altogether indicate a
direct interaction of both fluorescent dyes with both ABCB1
and ABCG2 in the low micromolar range.
Cytotoxicity of DCV Is Lower Than That of the Ho Dye
Since both DCV and Ho have been suggested to allow
sorting of side-population stem cells in flow cytometry for
further culturing (13,22), the effects of these dyes on cell sur-
vival should be estimated. In order to determine these effects,
we measured the concentration-dependent cytotoxicity of
both dyes in cultured K562 and A431 cancer cell lines in a
72 h cell survival assays. A431 cells were engineered to stably
express a fluorescent marker protein, mOrange, to be used as
a viability indicator, which allows in situ a continuous detec-
tion of cell survival (Toth et al., unpublished results).
As shown in FigureF2 2, both DCV and Ho were toxic in
both the parental K562 and A431 cells (Fig. 2A) with low
micromolar IC50 values (Fig. 2B). Still, DCV toxicity was
somewhat lower than Ho toxicity in both cell lines. Expression
of the multidrug transporters ABCB1 or ABCG2 significantly
reduced the toxicity of both dyes, as expected by the active
efflux mediated by these transporters. Interestingly, the pro-
tective activity of both ABCB1 and ABCG2 against DCV in
these cells was more pronounced than the protection against
Ho toxicity. Although the expression levels of the two ABC
transporters cannot be directly compared, in these
experiments the K562 cells expressing ABCG2 were more pro-
tected against DCV than cells expressing ABCB1.
All these data indicate that both DCV and Ho possess
strong cytotoxic effects. Still, side-population stem cells,
expressing preferentially ABCG2 and showing a reduced dye
uptake, may be efficiently sorted without significant effect on
cell viability in a DCV concentration range of 1–5 lM.
Comparison of DCV and Ho Uptake in ABCB1- and
ABCG2-Expressing Cell Lines as Measured by Flow
Cytometry
In the flow cytometry experiments shown in Figure F33, we
have examined the dye uptake in intact cells by flow cytome-
try, and measured ABC transporter expression in parallel by
antibody staining to correlate dye uptake and expression lev-
els. For antibody staining of ABCB1 and ABCG2 in intact
cells, we have used the cell-surface reactive specific monoclo-
nal antibodies MRK16 and 5D3, respectively (Fig. 3A). In
these studies we have also examined, if DCV or Ho is also
extruded by the third major multidrug transporter, ABCC1
(MRP1).
In the experiments shown in Figure 3, cellular Ho and
DCV fluorescence was measured after 20 min incubation of
parental, ABCG2-, or ABCB1-overexpressing K562 (Fig. 3B
and 3C) and A431 cells (Fig. 3B and 3D, Supporting Informa-
tion Fig. S1). The Ho or DCV concentration in the media was
1 lM.
As documented in Figure 3B–3D and Supporting Infor-
mation Fig. S1, both ABCG2- and ABCB1-expressing cells
actively extruded both the DCVand Ho fluorescent dyes, thus,
in these cells significantly lower fluorescence was observed
than in the parental cell lines. Dye extrusion was inhibited by
C
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Figure 1. Influence of DCV and Ho on the ATPase activity of ABCB1 and ABCG2 transporters. The modulatory effects of DCV and Ho on
the basalAQ5 and stimulated ATPase activities of ABCB1 (A) and ABCG2 (B) were studied in isolated Sf9 membrane preparations containing
the investigated transporter. In addition, cholesterol-loaded Sf9 membrane vesicles were used for the ABCG2 assays. For the stimulated
ATPase activity of ABCB1 and ABCG2, the experiments were performed in the presence of 1 lM Reversin 121 and 1 lM Quercetin, respec-
tively. The data points show the average of three independent experiments, the error bars represent SD values.
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specific transporter inhibitors, and in these cases dye uptake
increased to the levels observed in the parental cells.
From these measurements transport activity factors for
each transporter and each dye were calculated on the basis of
median fluorescence intensities measured in the presence and
absence of the specific inhibitor as described in the Materials
and Methods section. These data indicate that the activity fac-
tors determined either with DCV or with Ho provide a sensi-
tive method for the detection of transporter activity. No
substantial DCV or Ho extrusion was found in A431 cells
expressing ABCC1 (MRP1) (Fig. 3D).
The exact comparison of the DCVor Ho extrusion activi-
ty by the ABCB1 and ABCG2 transporters in these cellular
assays is not feasible, as neither the exact amounts of the
transporter proteins nor their dye affinity values can be direct-
ly determined. Moreover, excitation wavelength options in the
FACS instrument used for these experiments are better suited
for DCV than for Ho. However, ABCG2 cell lines showed
higher DCV extrusion capacity, which is in accordance with
the cytotoxicity results above.
Detection of ABCG2 Expression and Function in a
High Content Screening (HCS) System at a Single Cell
Level
In order to achieve large scale automatic detection and
identification of drug-resistant single cells, we developed a
real-time, fluorescence-based, automatic HCS assay. In these
experiments we have performed in situ HCS measurements to
follow DCV or Ho dye uptake in surface-adherent tumor cells
at 378C. In Figure F44, the results of DCV measurements are
presented, whereas similar experiments performed with Ho
are shown in Supporting Information Figure S2. The imaging
data can be properly quantitated and automatized by using
the HCS software, even when a large number of the wells are
examined in parallel measurements. After completing the dye
uptake measurements, we have also performed in situ immu-
nostaining of the same cell populations, in order to examine
how dye uptake correlates with transporter expression. Our
main goal was to study fluorescent dye uptake in a mixed pop-
ulation of parental and ABCG2 overexpressing cells, as a mod-
el of naturally heterogeneous tumor cell populations.
In this experiment, we have prepared mixed cell cultures
containing 98% of parental and 2% ABCG2-expressing A431
cells, and seeded onto 96 well plates. Following a 16 h incuba-
tion, the cells were subjected to 1 lM DCV and fluorescence
images were acquired in every 5 min for 150 min. At a given
time point a selective ABCG2 inhibitor, Ko143 was added to
the samples. At the end of the dye uptake measurement the
cells were fixed and in situ immunocytochemistry was per-
formed to visualize ABCG2 expression in the studied cells.
Figure 4A shows the kinetics of DCV uptake in several
cells selected from a large dataset. This analysis showed a con-
tinuous dye accumulation in the majority of cells, but also
identified some cells that showed very low dye uptake, which
was significantly accelerated upon the addition of Ko143. Sub-
sequent immunostaining with 5D3 antibody allowed us to
identify the ABCG2-expressing cells. Panels 1–3 in Figure 4B
show the microscopy images of cellular DCV fluorescence
C
O
L
O
R
Figure 2. Cellular toxicity of DCV and Ho in ABCB1- and ABCG2-expressing cell lines. (A) Cytotoxic effect of DCV and Ho in K562 and A431
parental, ABCB1- or ABCG2-expressing cells. K562 cell viability was determined by PrestoBlue staining, while in A431 cells expressing
mOrange fluorescent protein, viability was measured on the basis of mOrange fluorescence, which is proportional to the cell number.
Absorbance or fluorescence of untreated samples considered as 100% for each cell line. The graphs show the average of three indepen-
dent experiments, error bars indicate SD values. (B) Cytotoxicity was determined by IC50 values calculated by dose-response fitting of the
Origin software from the viability curves. Significant differences (Student’s t-test, P< 0.01) in the toxicity of Ho and DCV dyes in the same
cell lines are indicated by asterisks.
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obtained at the indicated time points (dye addition was per-
formed at 10 min). Panel 4 show the immunofluorescence
image of the same sample stained with 5D3 monoclonal
antibody following the DCV uptake measurement. As docu-
mented, A431 cells showing slow DCV uptake accurately cor-
respond to the 5D3 labeled, ABCG2-expressing cells.
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Figure 3. Flow cytometry assessment of immunofluorescence staining and fluorescent dye uptake in ABC transporter expressing cell lines.
(A) To test the cell surface expression of ABCB1 and ABCG2 in the studied K562 or A431 cell lines, parental, as well as ABCB1- or ABCG2-
overexpressing cells were labeled with anti-ABCB1 MRK-16 antibody, anti-ABCG2 5D3 antibody or an isotype control antibody (I.C.), fol-
lowed by a labeling with a Brilliant Violet 421-conjugated secondary antibody. The fluorescence of the stained samples was assessed by
flow cytometry. (B–D) DCV and Ho extrusion from K562 or A431 cells by various ABC multidrug transporters. Parental, ABCB1- and ABCG2-
overexpressing cells were subjected to DCV (1 lM) or Ho (1 lM) in the absence or the presence of the specific inhibitor of the transporter
proteins for 20 min. 5 lM elacridar, 5 lM Ko143, and 100 lMMK571 was used for the inhibition of ABCB1, ABCG2, and ABCC1, respectively.
Dye fluorescence in live cells was measured by flow cytometry. (B) Representative histograms for DCV uptake in the examined cell lines are
shown here, whereas histograms of Ho uptake are presented in Supporting Information Figure S1. Median values of these histograms were
determined by Attune Cytometric Software, and the transport activity factors were calculated as described in the Materials and Methods sec-
tion. The transport activity factors for DCV and Ho in K562 (C) and A431 (D) cell lines expressing the indicated ABC transporter were deter-
mined in at least three independent experiments. Error bars represent SD values; asterisks indicate significant differences (P< 0.01).
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Figure 4C and 4D demonstrates a correlation analysis of
DCVuptake and 5D3 binding on a large dataset. For this anal-
ysis, the results of HCS experiments similar to that demon-
strated for selected cells in Figure 4A and 4B were used. On
the basis of blue fluorescence of DCV, an identification num-
ber (Object ID) was assigned to each cell. Before the addition
of Ko143, dye accumulation in the majority of cells nearly pla-
teaued, whereas a minor population exhibited negligible dye
uptake (see Figure 4A). Since the fluorescence of the latter was
hardly detectable, identification of these nuclei before Ko143
addition was not feasible. Therefore, the transport activity fac-
tors cannot be calculated as described previously (21) and
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Figure 4. Detection of ABCG2 expression and function at a single cell level in 96 well plates by using high content screening (HCS) micros-
copy (A) DCV uptake in a mixed population of parental and ABCG2-expressing A431 cells was measured at 378C by acquiring microscopy
images every 5 min. The time courses of average fluorescent intensities of the nuclei of some representative cells in the population are
shown. Timing of the additions of DCV (1 lM) and Ko143 (5 lM) are indicated by the arrows. (B) Representative microscopy images taken
at the indicated time points demonstrate the nuclear accumulation of DCV (grey). Elapsed times after Ko143 indicator are also indicated.
Image 4 also illustrates the result of 5D3 antibody labeling (shown in red) preformed after completing the DCV uptake measurement. All
images are from the same field of view of the well. ABCG2-expressing cells are marked with a yellow dashed circle. Scale bar in Image 4
represents 50 lm. (C) DCV transport ratio in 5D31 and 5D32 cells. DCV uptake measurement combined with subsequent immunofluores-
cence staining, as shown in (A) and (B), was performed with a mixed population of parental and ABCG2-expressing A431 cells. DCV trans-
port ratios were calculated from the fluorescence of the individual cell nuclei as described in the Materials and Methods section. The
representative field of view contained over 700 cells, which were distinguished by an identification number (Object ID). Cells positive for
5D3 antibody labeling are indicated in red, while cells remained unstained are shown in black. (D) Box diagram shows the correlation
between DCV transport ratio and the 5D3 positivity of the cells in the same representative site shown in Panel C. Box diagram was pre-
pared by SPSS Software. The difference between the two groups is significant by Student’s t-test, P< 0.01.
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used for the quantitative analysis of DCV uptake measure-
ments by flow cytometry (Fig. 3C and 3D). To overcome this
problem, for quantitative analysis of the HCS measurements,
two time points were selected, 15 and 60 min after the addi-
tion of Ko143. The fluorescence intensities of the nucleus of
each cell were determined at these two time points (F1 and F2,
respectively). A measure for the dye extrusion activity of the
transporter, “DCV transport ratio” was calculated for each cell
as F2/F1. On the basis of the immunofluorescence staining
ABCG2-expressing (5D31) and non-expressing (5D32) cell
were identified. When the DCV transport ratio values are
plotted against the Object ID, marking the 5D31 cells with
red, a strong correlation between DCV transport and ABCG2
expression can be observed (Fig. 4C). Accordingly, 5D31 cells
possess significantly higher DCV transport ratio than 5D32
cells (Fig. 4D).
DISCUSSION
ABC multidrug transporters have a key role in the devel-
opment of cancer chemotherapy resistance, thus it is of major
importance to determine functional transporter expression.
Sensitive detection is especially important for targeted therapies
and for the identification of highly drug-resistant, potential
tumor stem cells. Tumor stem cells are characterized by high
tumor renewal potential, while stem cell populations selected
and isolated by any methods were found to be heterogeneous
both for ABC transporters and stem cell markers (6–8).
It is generally accepted that stem cells can be isolated as a
side population after Ho (22–25) or DCV dye (11–13,26–28)
staining of living cells. These cells were found to express
ABCG2 (25), while in several other cases they express ABCB1
(10,24,29). Still, elevated ABC transporter expression has not
been accepted as exclusive stem cell characteristics in many
tumor types. In a comprehensive study of ovarian cancer cell
lines it was found that after a few passages of ABC
transporter-positive side population cells, the transporter-
negative population reappeared (26,30). In addition, only a
certain fraction of the Ho-selected side population cells
showed other stem cell features (30). Despite these uncertain-
ties, side population identification is widely used as a first step
in stem cell isolation, and proper conditions as well as sensi-
tive methods can increase the selectivity for better defined
stem cell populations (8,10,24,25,31).
In this work we analyzed the dye interactions with the
key ABC multidrug transporters and developed a HCS
imaging-based, combined functional and protein expression
analysis for the sensitive detection of ABC multidrug trans-
porters in individual cells of heterogeneous cell populations.
The DCV dye resembles the Ho dye in several aspects, but
here we document that DCV is more suitable for various
instruments in terms of fluorescence parameters, and better
applicable in the ABC transporter assays for several reasons.
Direct transporter-dye interaction was examined by mea-
suring ABC-ATPase activity in a membrane vesicle assay. Both
DCV and Ho dye inhibited ATPase activity of ABCG2 and
ABCB1 in a concentration-dependent manner, suggesting that
these dyes are slowly transported substrates. In the ABCG2-
ATPase assay the IC50 value of DCV was slightly higher than
that of Ho, which may indicate a different, probably higher
transport rate for DCV.
Although both DCV and Ho, as DNA binding dyes, are
potentially toxic compounds, earlier studies showed that, at least
in short term experiments, none of these dyes caused significant
reduction in cell viability or changes in gene expression (10).
Here we demonstrate in two cancer cell lines (K562 and A431)
that both dyes are toxic in micromolar concentrations. Still, the
effective toxic concentration of DCV is significantly higher than
that of Ho, and the difference is even more pronounced in cell
lines expressing the ABCB1 or ABCG2 transporters. Thus, DCV
is preferred over Ho regarding their toxicity.
Various flow cytometry assays have already been devel-
oped for these clinically important multidrug transporters by
using transporter positive and negative cell line pairs and fluo-
rescent indicator substrates (32,33). Our results here show
that DCV is an excellent indicator in this regard and we
assume that it can also be applied for screening transporter
inhibitors.
An important point in this work is the development of a
new HCS application by using DCV for following ABC trans-
porter activity in single cells. High throughput flow cytometry
(32,33) and high content imaging (34,35) are both applicable
to screen for substrates and inhibitors of ABC transporters,
but HCS has the key advantage to allow these studies in situ,
in surface-attached living cells. In addition, both transporter
activity assay and immunostaining can be performed in a
mixed cell population.
As a model for heterogeneous cancer cell populations, we
used the parental and ABCG2-overexpressing A431 cells. Here
we document that after a careful optimization of DCV con-
centrations and timing of the dye uptake experiments, DCV
can be used to identify even a low number of ABCG2-positive
cells in a large non-expressing population. DCV toxicity was
negligible in the applied concentration and time frame, and
the selection of transporter-positive cells based on DCV stain-
ing closely correlated with ABCG2-specific antibody staining.
Thus, side-population selection by DCV dye uptake measure-
ments in HCS microscopy can be combined with parallel anti-
body staining for various potential stem cell markers,
providing a great advantage in characterizing the low number
of cancer stem cells.
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